Topic

Washington

A collection of 516 issues

Myths vs. Facts: Getting Naglazyme (Galsulfase) Covered by Blue Cross Blue Shield in Washington

Quick Answer: Getting Naglazyme (galsulfase) covered by Blue Cross Blue Shield in Washington requires prior authorization with confirmed MPS VI diagnosis via enzyme assay, genetic testing, and clinical documentation. If denied, you have 180 days to appeal internally, then can request external review through Washington's Insurance Commissioner within

Coding That Helps Get Advate (octocog alfa) Approved by Blue Cross Blue Shield in Washington (ICD-10, HCPCS, NDC Guide)

Quick Answer: Getting Advate Covered in Washington Blue Cross Blue Shield of Washington requires prior authorization for Advate (octocog alfa) using specific medical codes. Use ICD-10 code D66 (hereditary factor VIII deficiency), HCPCS J7192 (factor VIII recombinant, per IU), and the product NDC. Submit via Premera's Availity portal

How to Get Firazyr (Icatibant) Covered by Cigna in Washington: Appeals Process, Forms, and State Protections

Quick Answer: Getting Firazyr (Icatibant) Covered by Cigna in Washington Firazyr (icatibant) requires prior authorization from Cigna, typically managed through Express Scripts/Accredo. If denied, Washington residents have strong appeal rights: internal appeals within 180 days, followed by binding external review through an Independent Review Organization (IRO) within 120 days.

How to Get Venclexta (venetoclax) Covered by Cigna in Washington: Appeals Guide with Forms and Timelines

Answer Box: Getting Venclexta Covered by Cigna in Washington Cigna requires prior authorization for Venclexta (venetoclax) processed through Express Scripts/Accredo in 2-5 business days. For CLL/SLL, you need ≥1 prior systemic therapy or del(17p)/TP53 mutation with chemoimmunotherapy failure. For AML, requires age ≥75 or comorbidities with

How to Get Brineura (Cerliponase Alfa) Covered by Humana in Washington: Prior Authorization Guide and Appeals Process

Answer Box: Getting Brineura Covered by Humana in Washington Brineura (cerliponase alfa) requires prior authorization from Humana for CLN2 disease patients ≥3 years old. Submit a formulary exception request with medical necessity documentation including TPP1 enzyme deficiency confirmation, specialized center capability, and neurosurgical device placement plans. If denied, you have

How to Get Stelara (ustekinumab) Covered by Aetna (CVS Health) in Washington: Complete Guide to Prior Authorization, Appeals, and External Review

Answer Box: Getting Stelara (ustekinumab) Covered by Aetna (CVS Health) in Washington Stelara requires prior authorization from Aetna with step therapy requirements (failed conventional treatments like methotrexate or TNF inhibitors), negative TB screening within 12 months, and specialist documentation. Fastest path: Call Aetna at 1-888-632-3862 to confirm your plan'

How Long Does It Take to Get Abecma (idecabtagene vicleucel) Approved by Blue Cross Blue Shield in Washington? Complete Timeline & Appeals Guide

Answer Box: Fastest Path to Abecma Approval Blue Cross Blue Shield plans in Washington (Premera, Regence) typically process Abecma prior authorization in 1-5 business days for standard requests, 72 hours for urgent cases. Submit complete documentation including ≥2 prior therapy failures (IMiD, proteasome inhibitor, anti-CD38), recent labs, and treatment at

How to Get Elaprase (idursulfase) Covered by UnitedHealthcare in Washington: Prior Authorization Guide and Appeal Process

Answer Box: Getting Elaprase (idursulfase) Covered in Washington To get Elaprase (idursulfase) approved by UnitedHealthcare in Washington, you need: (1) prior authorization with genetic/enzymatic confirmation of Hunter syndrome (MPS II), (2) weight-based dosing calculations, and (3) an infusion monitoring plan. If denied, Washington gives you 60 days to request

How to Get Filsuvez Covered by Humana in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Filsuvez Covered by Humana in Washington Humana Medicare Advantage plans require prior authorization for Filsuvez (birch triterpenes topical gel) to treat confirmed dystrophic or junctional epidermolysis bullosa in patients ≥6 months old. Success requires genetic testing results (COL7A1, LAMA3), wound documentation (10-50 cm²), and failed prior treatments.

How to Get Nucala (Mepolizumab) Covered by UnitedHealthcare in Washington: State Appeals Guide with Forms and Timelines

Answer Box: Getting Nucala Covered in Washington Washington residents have strong protections when UnitedHealthcare denies Nucala (mepolizumab) for severe eosinophilic asthma. State law requires step therapy exceptions within 72 hours if prior biologics failed or are contraindicated. After internal appeals, you can request binding external review through an Independent Review